Results 71 to 80 of about 74,841 (314)
The Hidden Burden of Hemifacial Spasm: A Systematic Review of Non‐Motor Symptoms
Movement Disorders Clinical Practice, EarlyView.Abstract Background Hemifacial spasm (HFS) is a chronic neurological disorder characterized by involuntary contractions of facial muscles. Traditionally regarded as a motor condition, HFS encompasses a spectrum of non‐motor symptoms that are often overlooked but significantly affect patients’ quality of life.
Miriam Carvalho Soares +2 more
wiley +1 more source
Botulinum Toxin for the Treatment of Tremors
ToxinsTremor, an oscillatory movement disorder, is commonly encountered in clinical practice in the setting of a variety of etiologies, such as essential tremor and Parkinson’s disease. Despite its high prevalence, treatment options are somewhat limited.
Steven Bellows, Joseph Jankovic
doaj +1 more source
Development of an Innovative in Vitro Potency Assay for Anti-Botulinum Antitoxins
Toxins, 2016 Botulinum neurotoxins are bacterial proteins that cause botulism, a life-threatening disease. Therapy relies mostly on post-intoxication antibody treatment. The only accepted method to measure the potency of, and to approve, antitoxin preparations is the
Osnat Rosen +4 more
doaj +1 more source
Movement Disorders Clinical Practice, EarlyView.Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz +2 more
wiley +1 more source
Orofacial Drinking Tremor: A Case Series and Literature Review
Movement Disorders Clinical Practice, EarlyView.Abstract Background Task‐specific orofacial tremor is a rare condition in which rhythmic oscillations of orofacial muscles occur during specific actions. Drinking tremor represents a recurrent pattern in isolated reports, although its phenomenology and underlying mechanisms remain incompletely defined.
Daniele Birreci +7 more
wiley +1 more source
, 2016 <p><b>UNLABELLED: </b>Group II nonproteolytic Clostridium botulinum (gIICb) strains are an important concern for the safety of minimally processed ready-to-eat foods, because they can grow and produce botulinum neurotoxin during ...
C.W. Michiels +3 more
core +1 more source
RÜLFS CRAMP AND OTHER PAROXYSMAL DYSKINESIA
Эпилепсия и пароксизмальные состояния, 2016 Paroxysmal dyskinesia comprise a significant and fascinating part of movement disorders, which represent a diagnostic challenge for neurologists working on the borderlands of psychiatry and epilepsy.
M. V. Selikhova +4 more
doaj
Esthetics in ophthalmology: Noninvasive options of facial rejuvenation
TNOA Journal of Ophthalmic Science and Research, 2018 Facial aging is an ongoing biological process governed by both intrinsic and extrinsic factors. Conventionally, surgical treatments remained superior for decades due to satisfactory outcome.
Atanu Barh, Bipasha Mukherjee
doaj +1 more source
CLOSTRIDIUM BOTULINUM IN FOOD SUBSTRATES: MONITORING AND PREVENTION
, 2023 openL’elaborato tratta del Clostridium botulinum, un patogeno alimentare che causa la patologia del botulismo. La tossina botulinica, infatti, viene assorbita dalla mucosa intestinale, arriva nel sangue e raggiunge le terminazioni neuromuscolari dove ...
TORREGGIANI, SARA
core
Movement Disorders Clinical Practice, EarlyView.Abstract Background Hyperkinetic movement disorders, including dystonia, tremor, and myoclonus, are disabling conditions often managed with botulinum toxin type A (BoNT‐A). Real‐world evidence on treatment patterns remains limited. Objective This nationwide, population‐based study aimed to evaluate trends in BoNT‐A use in France between 2015 and 2023 ...
Marion Simonetta‐Moreau +3 more
wiley +1 more source